| Literature DB >> 28124601 |
Nikita G Nikiforov1, Natalia V Elizova1, Michael Bukrinsky2, Larisa Dubrovsky2, Vsevolod J Makeev3, Yoshiyuki Wakabayashi4, Poching Liu4, Kathy K Foxx5, Howard S Kruth6, Xueting Jin6, Emile R Zakiev7, Alexander N Orekhov8.
Abstract
In this mini-review, the role of macrophage phenotypes in atherogenesis is considered. Recent studies on distribution of M1 and M2 macrophages in different types of atherosclerotic lesions indicate that macrophages exhibit a high degree of plasticity of phenotype in response to various conditions in microenvironment. The effect of the accumulation of cholesterol, a key event in atherogenesis, on the macrophage phenotype is also discussed. The article presents the results of transcriptome analysis of cholesterol-loaded macrophages revealing genes involved in immune response whose expression rate has changed the most. It turned out that the interaction of macrophages with modified LDL leads to higher expression levels of pro-inflammatory marker TNF-α and antiinflammatory marker CCL18. Phenotypic profile of macrophage activation could be a good target for testing of novel anti-atherogenic immunocorrectors. A number of anti-atherogenic drugs were tested as potential immunocorrectors using primary macrophage-based model. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.Entities:
Keywords: Atherosclerosis; activation; immunocorrectors; macrophage-based test; macrophages; modified LDL; phenotype; transcriptome
Mesh:
Substances:
Year: 2017 PMID: 28124601 PMCID: PMC6446906 DOI: 10.2174/1381612823666170125110128
Source DB: PubMed Journal: Curr Pharm Des ISSN: 1381-6128 Impact factor: 3.116